Marc Ferrante - Concepedia

Author

Marc Ferrante

Also Known As

FERRANTE M, FERRANTE M, Ferrante M, Ferrante, Marc, Ferrante, Mariantonietta, J -F Rahier, M De Vos, M FERRANTE, M Ferrante, M. A. Ferrante

Publications

32.9K

Citations

H-Index

157

Concepts

All Affiliations

KU Leuven Universitair Ziekenhuis Leuven Imelda Hospital University of Liège Amsterdam University Medical Centers

About

Marc Ferrante is an author at KU Leuven specializing in medicine, gastroenterology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	63	11.7K
2	Allergy	7	7	717
3	Health Sciences	5	5	463
4	Engineering	3	3	579
5	Public Health	3	3	303

Marc Ferrante

248

Publications

28.7K

Citations

H-Index

Page 1

	Year	Citations
Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium Toshiro Sato, Daniel E. Stange, Marc Ferrante, Gastroenterology Gastrointestinal OncologyMedicineGastroenterologyColorectal CancerPathology	2011	3.7K
A decrease of the butyrate-producing species <i>Roseburia hominis</i> and <i>Faecalibacterium prausnitzii</i> defines dysbiosis in patients with ulcerative colitis Kathleen Machiels, Marie Joossens, João Sabino, Gut	2013	1.8K
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial Julián Panés, Damián García‐Olmo, Gert Van Assche, The Lancet Regenerative MedicineInflammationComplex Perianal FistulasMedicineGastroenterology	2016	1K
Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease Niels Vande Casteele, Marc Ferrante, Gert Van Assche, Gastroenterology Trough ConcentrationsInflammationAnti-inflammatoryGastroenterologyPharmacotherapy	2015	859
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease Geert D’Haens, Marc Ferrante, Séverine Vermeire, Inflammatory Bowel Diseases	2012	797
Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease Fabian Schnitzler, Herma H. Fidder, Marc Ferrante, Inflammatory Bowel Diseases	2009	669
Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort Fabian Schnitzler, Herma H. Fidder, Marc Ferrante, Gut	2008	530
Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease Konstantinos Κarmiris, Gilles Paintaud, Maja Noman, Gastroenterology InflammationChronic Inflammatory DiseasesRheumatoid DisorderAllergyAutoimmune Disease	2009	477
Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening Matteo Boretto, Nina Maenhoudt, Xinlong Luo, Nature Cell Biology Uterine FibroidsMedicineUterine ReceptivityImplantation (Embryology)Gynecology	2019	467
Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study Herma H. Fidder, Fabian Schnitzler, Marc Ferrante, Gut	2008	448

Page 1